-
Je něco špatně v tomto záznamu ?
Neuroimaging of Parkinson's disease by quantitative susceptibility mapping
X. Guan, M. Lancione, S. Ayton, P. Dusek, C. Langkammer, M. Zhang
Jazyk angličtina Země Spojené státy americké
Typ dokumentu přehledy, časopisecké články
NLK
Directory of Open Access Journals
od 2020
ProQuest Central
od 1998-05-01 do Před 2 měsíci
Health & Medicine (ProQuest)
od 2002-08-01 do Před 2 měsíci
Psychology Database (ProQuest)
od 2002-08-01 do Před 2 měsíci
ROAD: Directory of Open Access Scholarly Resources
- MeSH
- biologické markery MeSH
- lidé MeSH
- magnetická rezonanční tomografie metody MeSH
- mapování mozku metody MeSH
- neurodegenerativní nemoci * MeSH
- neurozobrazování MeSH
- Parkinsonova nemoc * diagnostické zobrazování patologie MeSH
- progrese nemoci MeSH
- železo MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Parkinson's disease (PD) is a common neurodegenerative disease, and apart from a few rare genetic causes, its pathogenesis remains largely unclear. Recent scientific interest has been captured by the involvement of iron biochemistry and the disruption of iron homeostasis, particularly within the brain regions specifically affected in PD. The advent of Quantitative Susceptibility Mapping (QSM) has enabled non-invasive quantification of brain iron in vivo by MRI, which has contributed to the understanding of iron-associated pathogenesis and has the potential for the development of iron-based biomarkers in PD. This review elucidates the biochemical underpinnings of brain iron accumulation, details advancements in iron-sensitive MRI technologies, and discusses the role of QSM as a biomarker of iron deposition in PD. Despite considerable progress, several challenges impede its clinical application after a decade of QSM studies. The initiation of multi-site research is warranted for developing robust, interpretable, and disease-specific biomarkers for monitoring PD disease progression.
Department of Neurology Medical University of Graz Austria
Florey Institute The University of Melbourne Australia
Laboratory of Medical Physics and Magnetic Resonance IRCCS Stella Maris Foundation Pisa Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24006544
- 003
- CZ-PrNML
- 005
- 20240423155337.0
- 007
- ta
- 008
- 240412e20240218xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.neuroimage.2024.120547 $2 doi
- 035 __
- $a (PubMed)38373677
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Guan, Xiaojun $u Department of Radiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Joint Laboratory of Clinical Radiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, No.88 Jiefang Road, Shangcheng District, Hangzhou 31009, China
- 245 10
- $a Neuroimaging of Parkinson's disease by quantitative susceptibility mapping / $c X. Guan, M. Lancione, S. Ayton, P. Dusek, C. Langkammer, M. Zhang
- 520 9_
- $a Parkinson's disease (PD) is a common neurodegenerative disease, and apart from a few rare genetic causes, its pathogenesis remains largely unclear. Recent scientific interest has been captured by the involvement of iron biochemistry and the disruption of iron homeostasis, particularly within the brain regions specifically affected in PD. The advent of Quantitative Susceptibility Mapping (QSM) has enabled non-invasive quantification of brain iron in vivo by MRI, which has contributed to the understanding of iron-associated pathogenesis and has the potential for the development of iron-based biomarkers in PD. This review elucidates the biochemical underpinnings of brain iron accumulation, details advancements in iron-sensitive MRI technologies, and discusses the role of QSM as a biomarker of iron deposition in PD. Despite considerable progress, several challenges impede its clinical application after a decade of QSM studies. The initiation of multi-site research is warranted for developing robust, interpretable, and disease-specific biomarkers for monitoring PD disease progression.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a Parkinsonova nemoc $x diagnostické zobrazování $x patologie $7 D010300
- 650 12
- $a neurodegenerativní nemoci $7 D019636
- 650 _2
- $a neurozobrazování $7 D059906
- 650 _2
- $a magnetická rezonanční tomografie $x metody $7 D008279
- 650 _2
- $a biologické markery $7 D015415
- 650 _2
- $a železo $7 D007501
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a mapování mozku $x metody $7 D001931
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Lancione, Marta $u Laboratory of Medical Physics and Magnetic Resonance, IRCCS Stella Maris Foundation, Pisa, Italy
- 700 1_
- $a Ayton, Scott $u Florey Institute, The University of Melbourne, Australia
- 700 1_
- $a Dusek, Petr $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia; Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Auenbruggerplatz 22, Prague 8036, Czechia
- 700 1_
- $a Langkammer, Christian $u Department of Neurology, Medical University of Graz, Austria. Electronic address: christian.langkammer@medunigraz.at
- 700 1_
- $a Zhang, Minming $u Department of Radiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Joint Laboratory of Clinical Radiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, No.88 Jiefang Road, Shangcheng District, Hangzhou 31009, China. Electronic address: zhangminming@zju.edu.cn
- 773 0_
- $w MED00006575 $t NeuroImage $x 1095-9572 $g Roč. 289 (20240218), s. 120547
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38373677 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423155334 $b ABA008
- 999 __
- $a ok $b bmc $g 2080875 $s 1216311
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 289 $c - $d 120547 $e 20240218 $i 1095-9572 $m NeuroImage $n Neuroimage $x MED00006575
- LZP __
- $a Pubmed-20240412